Evidence for Efficacy of Antidepressants for Pain Is Limited
In 11 comparisons, antidepressants were efficacious, but they were inefficacious or evidence was inconclusive for 31 comparisons
In 11 comparisons, antidepressants were efficacious, but they were inefficacious or evidence was inconclusive for 31 comparisons
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
The 2022 CDC Clinical Practice Guideline is intended to help clinicians weigh the benefits and risks of opioids and alternative pain treatments for outpatients.
Opioids no more effective than NSAIDs or local, systemic anesthetics for musculoskeletal pain, may carry higher risks for harms
Postoperative consumption of opioids over six weeks reduced with multimodal opioid-sparing protocol for managing pain following arthroscopic shoulder or knee surgery
The table provided is a review of notable updates that occurred in September 2022 for investigational products in development.
Iheezo is a sterile, preservative-free, single-patient use, ophthalmic gel preparation.
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
SP-103 is a next generation triple strength formulation of ZTlido (lidocaine topical system) 1.8%.
The designation was based on data from two phase 2 proof-of-concept studies that evaluated VX-548 for acute pain following abdominoplasty or bunionectomy surgery.